The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa

Dermatology

Volumn 219, Issue 2, 2009, Pages 143-147

  Van Der Zee, Hessel H ^a   Boer, Jurr ^b   Prens, Errol P ^a   Jemec, Gregor B E ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEVENTER HOSPITAL   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acne inversa; Antibiotics therapy; Clindamycin; Rifampicin

Indexed keywords

CLINDAMYCIN; RIFAMPICIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; GLOSSODYNIA; HUMAN; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SUPPURATIVE HIDRADENITIS; TREATMENT DURATION; TREATMENT RESPONSE; VAGINA CANDIDIASIS;

ADMINISTRATION, ORAL; ADULT; CLINDAMYCIN; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RIFAMPIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69349101576     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228337     Document Type: Article

References (30)

1. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji- Garin S: Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008; 59: 596-601.
2. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J, Quality of Life Group of the French Society of Dermatology: Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621-623.
3. Von der Werth JM, Jemec GB: Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809-813.
4. Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, Nagy I, Bechara FG, Sartorius K, Lapins J, Krahl D, Altmeyer P, Revuz J, Zouboulis CC: What causes hidradenitis suppurativa? Exp Dermatol 2008; 17: 455-456, discussion 457-472.
5. Boer J, Weltevreden EF: Hidradenits suppurativa or acne inversa: a clinicopathological study of early lesions. Br J Dermatol 1996; 135: 721-725. (Pubitemid 26375888)
6. Jemec GB, Hansen U: Histology of hidradenitis suppurativa. J Am Acad Dermatol 1996; 34: 994-999.
7. Jemec GB, Faber M, Gutschik E, Wendelboe P: The bacteriology of hidradenitis suppurativa. Dermatology 1996; 193: 203-206.
8. Lapins J, Jarstrand C, Emtestam L: Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 1999; 140: 90-95. (Pubitemid 29074537)
9. Sartorius K, Lapins J, Jalal S, Emtestam L, Hedberg M: Bacteraemia in patients with hidradenitis suppurativa undergoing carbon dioxide laser surgery: detection and quantification of bacteria by lysis-filtration. Dermatology 2006; 213: 305-312. (Pubitemid 44837018)
10. Clemmensen OJ: Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983; 22: 325-328.
11. Jemec GB, Wendelboe P: Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971-974.
12. Brenner DE, Lookingbill DP: Anaerobic microorganisms in chronic suppurative hidradenitis. Lancet 1980; 2: 921-922. (Pubitemid 10014334)
13. Brooke RCC, Griffiths CEM: Folliculitis decalvans. Clin Exp Dermatol 2001; 26: 120-122.
14. Powell JJ, Dawber RPR, Gatter K: Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 1999; 140: 428-433.
15. Mendonça CO, Griffiths CE: Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 2006; 154: 977-978.
16. Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Gardin S: Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 2009;219:148-154.
17. Hurley HJ: Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach; in Roenigh RK, Roenigh HH (eds): Dermatologic Surgery. New York, Dekker, 1989, pp 729-739.
18. Rose RF, Goodfield MJ, Clark SM: Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin. Clin Exp Dermatol 2006; 31: 154-155.
19. Kaur MR, Lewis HM: Hidradenitis suppurativa treated with dapsone: a case series of five patients. J Dermatol Treat 2006; 17: 211-213. (Pubitemid 44395545)
20. Jemec GB: Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin Exp Dermatol 2002; 27: 528-529.
21. Kipping HF: How I treat hidradenitis suppurativa. Postgrad Med 1970; 48: 291-292.
22. Brunasso AM, Delfino C, Massone C: Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative? Br J Dermatol 2008; 159: 761-763.
23. Van Vlem B, Vanholder R, De Paepe P, Vogelaers D, Ringoir S: Immunomodulating effects of antibiotics: literature review. Infection 1996; 24: 275-291. (Pubitemid 26273294)
24. Sensi P: History of the development of rifampicin. Rev Infect Dis 1983; 5:S402-S406.
25. Lorber B: Rifampicin in the treatment of chronic granulomatous disease. N Engl J Med 1980; 303: 111.
26. Mandell GL: The antimicrobial activity of rifampicin - emphasis on relation to phagocytes. Rev Infect Dis 1983; 5:S463-S467.
27. Tsankov N, Angelova I: Rifampicin in dermatology. Clin Dermatol 2003; 21: 50-55.
28. Spizek J, Novotna J, Rezanka T: Lincosamines: chemical structure, biosynthesis, mechanism of action, resistance and applications. Adv Appl Microbiol 2004; 56: 121-154. (Pubitemid 39585142)
29. Pasquale TR, Tan JS: Nonantimicrobial effects of antibacterial agents. Clin Infect Dis 2005; 40: 127-135.
30. Renneberg J, Karlsson E, Nilsson B, Walder M: Interactions of drugs acting against Staphylococcus aureus in vitro and in a mouse model. J Infect 1993; 26: 265-277.